StockWatch
·
Medical/Nursing Services
Quarterly ResultAug 10, 2026, 06:15 AM

AirSculpt Q2 Revenue $42.9M, Net Loss $1.1M; Cuts FY26 EBITDA Outlook

AI Summary

AirSculpt Technologies reported mixed results for the second quarter of fiscal year 2026, with revenue declining 3% to $42.9 million and net loss increasing to $1.1 million. Despite a 1.0% growth in same center case volume and a new partnership with AlloClae, the company reduced its full-year 2026 Adjusted EBITDA outlook to $12-$14 million. The company also improved its financial flexibility by reducing gross debt by approximately $30 million to $44.2 million and amending its term loan agreement to extend maturity.

Key Highlights

  • Q2 2026 revenue declined 3% to $42.9 million.
  • Q2 2026 net loss increased to $1.1 million from $0.6 million.
  • Q2 2026 Adjusted EBITDA decreased to $4.9 million.
  • Full-year 2026 Adjusted EBITDA outlook cut to $12-$14 million.
  • Same center case volume grew 1.0% in Q2 2026.
  • Gross debt reduced by ~$30 million to $44.2 million.
  • Entered exclusive partnership with AlloClae for new procedures.
  • Amended term loan agreement, extending maturity to Nov 2027.